A novel reactive ester derivative of biotin with reduced membrane permeability for in vivo biotinylation experiments

Proteomics

Volumn 10, Issue 19, 2010, Pages 3544-3548

  Strassberger, Verena ^a   Trüssel, Sabrina ^a   Fugmann, Tim ^a   Neri, Dario ^a   Roesli, Christoph ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Biotin; In vivo biotinylation; Technology; Vascular biomarker

Indexed keywords

BIOLOGICAL MARKER; BIOTIN; BIOTIN DERIVATIVE; ESTER DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; IN VIVO STUDY; MEMBRANE PERMEABILITY; METHODOLOGY; MOUSE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; PROTEOMICS; VASCULARIZATION;

ANIMALS; BIOTIN; BIOTINYLATION; CELL MEMBRANE PERMEABILITY; KIDNEY; LIVER; MICE; PROTEINS; SUCCINIMIDES;

RODENTIA;

EID: 77957202105     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000308     Document Type: Article

References (13)

1. Schliemann, C., Neri, D., Antibody-based targeting of the tumor vasculature. Biochim. biophys. acta 2007, 1776, 175-192.
2. Elschenbroich, S., Kim, Y., Medin, J. A., Kislinger, T., Isolation of cell surface proteins for mass spectrometry-based proteomics. Expert Rev. Proteomics 2010, 7, 141-154.
3. Roesli, C., Neri, D., Methods for the identification of vascular markers in health and disease: From the bench to the clinic. J. Proteomics 2010. doi:10.1016/j.jprot.2010.05.017.
4. Rybak, J. N., Ettorre, A., Kaissling, B., Giavazzi, R. et al., In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature. Nature Methods 2005, 2, 291-298.
5. Strassberger, V., Fugmann, T., Neri, D., Roesli, C., Chemical proteomic and bioinformatic strategies for the identification and quantification of vascular antigens in cancer. J. Proteomics 2010. doi:10.1016/j.jprot.2010.05. 018.
6. Roesli, C., Neri, D., Rybak, J. N., In vivo protein biotinylation and sample preparation for the proteomic identification of organ- and disease-specific antigens accessible from the vasculature. Nature Protocols 2006, 1, 192-199.
7. Borgia, B., Roesli, C., Fugmann, T., Schliemann, C. et al., A proteomic approach for the identification of vascular markers of liver metastasis. Cancer Res. 2010, 70, 309-318.
8. Rybak, J. N., Roesli, C., Kaspar, M., Villa, A., Neri, D., The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res. 2007, 67, 10948-10957.
9. Schliemann, C., Roesli, C., Kamada, H., Borgia, B. et al., In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy. Blood 2010, 115, 736-744.
10. Villa, A., Trachsel, E., Kaspar, M., Schliemann, C. et al., A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo. Int. J. Cancer 2008, 122, 2405-2413.
11. Roesli, C., Borgia, B., Schliemann, C., Gunthert, M. et al., Comparative analysis of the membrane proteome of closely related metastatic and nonmetastatic tumor cells. Cancer Res. 2009, 69, 5406-5414.
12. Fugmann, T., Neri, D., Roesli, C., DeepQuanTR: MALDI-MS-based label-free quantification of proteins in complex biological samples. Proteomics 2010, 10, 2631-2643.
13. Carrillo, B., Yanofsky, C., Laboissiere, S., Nadon, R., Kearney, R. E., Methods for combining peptide intensities to estimate relative protein abundance. Bioinformatics 2010, 26, 98-103.